Conflict of Interest – Full Disclosure Statement Submission

Competing Interest and Disclosure Policy

Everyone who is in a position to control the content of an educational activity (e.g., faculty, authors, planning committees, editorial boards, etc.) must disclose to AMMI Canada all financial and other relationships with any commercial interest that might otherwise give rise to a competing interest.

The intent of this policy is not to prohibit speakers from presenting or members from participating on committees, but rather to inform the audience and/or membership of any bias that speakers or committee members may have.

Definition of a Conflict: A Conflict of Interest or Competing Interest may occur in situations where the personal and professional interests of individuals may have actual, potential or apparent influence over their judgment and actions.
  1. All financial or “in kind” relationships including that of spouses, children, and or immediate family members (not only those relevant to the subject being discussed) encompassing the previous two (2) calendar years must be disclosed.

  2. The following pages must be completed and submitted for review to AMMI Canada.

    Examples of relationships that must be disclosed include but are not limited to the following:
    1. Any direct financial interest in a commercial entity such as a pharmaceutical organization, medical devices company or communications firm (“the Organization”)
    2. Investments held in the Organization
    3. Membership on the Organization’s Advisory Board or similar committee
    4. Current or recent participation in a clinical trial sponsored by the Organization
    5. Member of a Speakers Bureau
    6. Holding a patent for a product referred to in the CME/CPD activity or that is marketed by a commercial organization
     For Speakers:
  1. It is the presenter’s responsibility to ensure that their presentation (and any recommendations) is balanced and reflects the current scientific literature. Unapproved use of products or services must be declared within the presentation. The only caveat to this guideline is where there is only one treatment or management strategy.

  2. Disclosure must be done verbally, displayed in writing on a slide at the beginning of a presentation and included in the written conference materials.

Failure to disclose or false disclosure may require the speaker or committee member to be replaced.

Powered by SimpleSurvey